
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.43 | 0.49 | 0.06 |
Shares | 99.56 | 99.56 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.53 | 19.69 |
Price to Book | 3.49 | 3.81 |
Price to Sales | 1.62 | 2.22 |
Price to Cash Flow | 12.21 | 14.69 |
Dividend Yield | 1.42 | 1.48 |
5 Years Earnings Growth | 9.27 | 10.02 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.05 | 94.95 |
Industrials | 0.95 | 2.63 |
Number of long holdings: 58
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 7.00 | 839.87 | +2.44% | |
AstraZeneca | GB0009895292 | 6.30 | 12,650.0 | +1.57% | |
Novo Nordisk B | DK0062498333 | 3.94 | 378.9 | +2.07% | |
UnitedHealth | US91324P1021 | 3.80 | 360.20 | +1.83% | |
Thermo Fisher Scientific | US8835561023 | 3.78 | 543.32 | +3.50% | |
Boston Scientific | US1011371077 | 3.41 | 97.32 | +1.14% | |
Intuitive Surgical | US46120E6023 | 3.35 | 452.35 | +2.11% | |
Sanofi | FR0000120578 | 3.26 | 86.80 | +2.07% | |
Fresenius SE | DE0005785604 | 2.87 | 47.160 | +0.32% | |
AbbVie | US00287Y1091 | 2.86 | 233.91 | -1.12% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AXA Framlington Global Technology a | 1.31B | 5.90 | 12.50 | 19.14 | ||
AXA Framlington Global Technology F | 1.31B | 5.90 | 12.50 | 19.14 | ||
GB00B5LXGG05 | 1.04B | -0.27 | 13.33 | 15.94 | ||
AXA Framlington Managed Income Fund | 268.46M | 5.22 | 6.73 | 4.64 | ||
AXA Framlington Managed Income Funa | 268.46M | 4.86 | 6.21 | 4.25 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review